Physician profile
Howard Cohen
NPI 1013913110
$1,097.83
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $749 · 2021: $92.68 · 2022: $47.64 · 2023: $16.11 · 2024: $31.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $47.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $47.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $600.00 | 2020 | |
| Abbott Laboratories | $98.54 | 2020 | |
| Boston Scientific Corporation | $75.25 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.58 | 2019-2024 | Jardiance |
| Amgen INC. | $56.47 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $48.80 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $44.81 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $26.48 | 2020 | |
| Biotronik INC. | $15.76 | 2019 | |
| Novo Nordisk INC | $15.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.91 | 2021 | |
| Amarin Pharma, INC. | $14.27 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.16 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.